| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-06-20 19:57:50 UTC |
|---|
| Updated at | 2021-06-30 00:08:49 UTC |
|---|
| NP-MRD ID | NP0036913 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | epi-4-udalactarane B |
|---|
| Provided By | JEOL Database |
|---|
| Description | (3R)-1-Oxo-3beta-[[(2aR)-2abeta-hydroxy-3,5,7abeta-trimethyl-2,2a,4,5,6,6aalpha,7,7a-octahydro-1H-cyclobuta[f]indene-5beta-yl]methoxy]-6,6-dimethyl-3aalpha,8aalpha-methano-3,3a,5,6,7,7aalpha,8,8a-octahydro-1H-indeno[5,6-c]furan-4-carbaldehyde belongs to the class of organic compounds known as terpene lactones. These are prenol lipids containing a lactone ring. epi-4-udalactarane B is found in Phlebia uda. epi-4-udalactarane B was first documented in 2012 (Schuffler, A., et al.). Based on a literature review very few articles have been published on (3R)-1-Oxo-3beta-[[(2aR)-2abeta-hydroxy-3,5,7abeta-trimethyl-2,2a,4,5,6,6aalpha,7,7a-octahydro-1H-cyclobuta[f]indene-5beta-yl]methoxy]-6,6-dimethyl-3aalpha,8aalpha-methano-3,3a,5,6,7,7aalpha,8,8a-octahydro-1H-indeno[5,6-c]furan-4-carbaldehyde. |
|---|
| Structure | [H]O[C@@]12C(=C3C([H])([H])[C@@](C([H])([H])[H])(C([H])([H])O[C@]4([H])OC(=O)[C@@]56C([H])([H])[C@@]45C(C([H])=O)=C4C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[C@@]4([H])C6([H])[H])C([H])([H])[C@@]3([H])C([H])([H])[C@]1(C([H])([H])[H])C([H])([H])C2([H])[H])C([H])([H])[H] InChI=1S/C30H40O5/c1-17-20-13-26(4,9-19(20)10-27(5)6-7-30(17,27)33)16-34-24-29-15-28(29,23(32)35-24)11-18-8-25(2,3)12-21(18)22(29)14-31/h14,18-19,24,33H,6-13,15-16H2,1-5H3/t18-,19-,24+,26-,27-,28+,29+,30-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (3R)-1-oxo-3b-[[(2AR)-2abeta-hydroxy-3,5,7abeta-trimethyl-2,2a,4,5,6,6aalpha,7,7a-octahydro-1H-cyclobuta[F]indene-5b-yl]methoxy]-6,6-dimethyl-3aalpha,8aalpha-methano-3,3a,5,6,7,7aalpha,8,8a-octahydro-1H-indeno[5,6-c]furan-4-carbaldehyde | Generator | | (3R)-1-oxo-3Β-[[(2ar)-2abeta-hydroxy-3,5,7abeta-trimethyl-2,2a,4,5,6,6aalpha,7,7a-octahydro-1H-cyclobuta[F]indene-5β-yl]methoxy]-6,6-dimethyl-3aalpha,8aalpha-methano-3,3a,5,6,7,7aalpha,8,8a-octahydro-1H-indeno[5,6-c]furan-4-carbaldehyde | Generator |
|
|---|
| Chemical Formula | C30H40O5 |
|---|
| Average Mass | 480.6450 Da |
|---|
| Monoisotopic Mass | 480.28757 Da |
|---|
| IUPAC Name | (1S,7S,9S,12R)-12-{[(2aS,3aS,5S,7aR)-7a-hydroxy-2a,5,7-trimethyl-1H,2H,2aH,3H,3aH,4H,5H,6H,7aH-cyclobuta[f]inden-5-yl]methoxy}-5,5-dimethyl-10-oxo-11-oxatetracyclo[7.3.1.0^{1,9}.0^{3,7}]tridec-2-ene-2-carbaldehyde |
|---|
| Traditional Name | (1S,7S,9S,12R)-12-{[(2aR,5S,6aS,7aS)-2a-hydroxy-3,5,7a-trimethyl-1H,2H,4H,6H,6aH,7H-cyclobuta[f]inden-5-yl]methoxy}-5,5-dimethyl-10-oxo-11-oxatetracyclo[7.3.1.0^{1,9}.0^{3,7}]tridec-2-ene-2-carbaldehyde |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H]O[C@@]12C(=C3C([H])([H])[C@@](C([H])([H])[H])(C([H])([H])O[C@]4([H])OC(=O)[C@@]56C([H])([H])[C@@]45C(C([H])=O)=C4C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[C@@]4([H])C6([H])[H])C([H])([H])[C@@]3([H])C([H])([H])[C@]1(C([H])([H])[H])C([H])([H])C2([H])[H])C([H])([H])[H] |
|---|
| InChI Identifier | InChI=1S/C30H40O5/c1-17-20-13-26(4,9-19(20)10-27(5)6-7-30(17,27)33)16-34-24-29-15-28(29,23(32)35-24)11-18-8-25(2,3)12-21(18)22(29)14-31/h14,18-19,24,33H,6-13,15-16H2,1-5H3/t18-,19-,24+,26-,27-,28+,29+,30-/m0/s1 |
|---|
| InChI Key | JVSGWCCMXPFMRE-NDCOXDJSSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CD3Cl, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Phlebia uda | JEOL database | - Schuffler, A., et al, J. Nat. Prod. 75, 1405 (2012)
|
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as terpene lactones. These are prenol lipids containing a lactone ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Terpene lactones |
|---|
| Direct Parent | Terpene lactones |
|---|
| Alternative Parents | |
|---|
| Substituents | - Terpene lactone
- Sesquiterpenoid
- Sterpuran sesquiterpenoid
- Delta valerolactone
- Delta_valerolactone
- Gamma butyrolactone
- Oxane
- Tetrahydrofuran
- Tertiary alcohol
- Carboxylic acid ester
- Cyclobutanol
- Lactone
- Monocarboxylic acid or derivatives
- Acetal
- Carboxylic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Aldehyde
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Alcohol
- Carbonyl group
- Organooxygen compound
- Aliphatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aliphatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|